Lynch Asset Management’s Pfizer PFE Stock Holding History

Lynch Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-35,800	Closed	-$891K	–	53
2025 Q4	$891K	Sell	35,800 -8,700	-20%	-$219K	0.28%	40
2025 Q3	$1.13M	Sell	44,500 -2,200	-5%	-$54.3K	0.36%	39
2025 Q2	$1.13M	Hold	46,700	–	–	0.4%	40
2025 Q1	$1.18M	Buy	46,700 +1,200	+3%	+$31.4K	0.53%	37
2024 Q4	$1.21M	Buy	45,500 +600	+1%	+$16.3K	0.49%	37
2024 Q3	$1.3M	Buy	44,900 +400	+0.9%	+$11.7K	0.55%	37
2024 Q2	$1.25M	Hold	44,500	–	–	0.53%	36
2024 Q1	$1.23M	Buy	44,500 +6,200	+16%	+$172K	0.58%	35
2023 Q4	$1.1M	Buy	38,300 +18,300	+92%	+$553K	0.63%	37
2023 Q3	$663K	Hold	20,000	–	–	0.44%	38
2023 Q2	$734K	Hold	20,000	–	–	0.47%	40
2023 Q1	$816K	Buy	20,000 +5,000	+33%	+$216K	0.59%	37
2022 Q4	$769K	Hold	15,000	–	–	0.66%	38
2022 Q3	$657K	Hold	15,000	–	–	0.59%	38
2022 Q2	$786K	Hold	15,000	–	–	0.64%	36
2022 Q1	$777K	Hold	15,000	–	–	0.56%	34
2021 Q4	$885K	Buy	+15,000	New	+$743K	0.61%	35

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Lynch Asset Management's PFE Position: Q1 2026 in Review

Lynch Asset Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 35,800 shares — an estimated $891K sold.

Lynch Asset Management first reported a position in PFE in Q4 2021 and held it in 17 quarters. The position peaked at $1.3M in Q3 2024. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Lynch Asset Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
Lynch Asset Management sold 35,800 Pfizer shares in Q1 2026, an estimated $891K.
Lynch Asset Management first reported a position in Pfizer in Q4 2021 and held it in 17 quarters.
Lynch Asset Management's Pfizer position peaked at $1.3M in Q3 2024.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Lynch Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.